Financhill
Back

PDD Holdings Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
66

PDD
PDD Holdings

Last Price:
115.48
Seasonality Move:
28.94%
Sell
48

HALO
Halozyme Therapeutics

Last Price:
38.61
Seasonality Move:
4.07%
Buy
66
PDD Holdings (PDD) is a Buy

Is PDD Holdings a Buy, Sell or Hold?

  • The current PDD Holdings [PDD] share price is $115.53. The Score for PDD is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • PDD is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $38.62. The Score for HALO is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PDD Stock Price Chart

What is PDD Holdings's stock price today?

  • The PDD Holdings share price today is $115.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PDD is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $38.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

PDD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.68 Sell
Relative Strength Index (14 RSI): 41.45 Sell
Chaikin Money Flow: -6276582 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (115.42 - 124.88) Sell
Bollinger Bands (100): (120.29 - 143.99) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 40.8 Sell
Chaikin Money Flow: -486889 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.71 - 41.21) Sell
Bollinger Bands (100): (35.64 - 40.8) Buy

PDD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 118.75 Sell
20-day SMA: 120.9 Sell
50-day SMA: 123.53 Sell
200-day SMA: 112.27 Buy
8-day EMA: 118.76 Sell
20-day EMA: 120.03 Sell
50-day EMA: 123.62 Sell
200-day EMA: 114.29 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.79 Sell
20-day SMA: 40.23 Sell
50-day SMA: 39.04 Sell
200-day SMA: 38.73 Sell
8-day EMA: 39.64 Sell
20-day EMA: 39.98 Sell
50-day EMA: 39.32 Sell
200-day EMA: 38.84 Sell

PDD Holdings Earnings Growth & PDD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.14 per share, a decrease next quarter of $0.14 per share, an increase this year of $2.68 per share, and an increase next year of $2.40 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.30 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.91 per share, and an increase next year of $0.88 per share.

PDD Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):